Biohaven Pharmaceutical Holding Co Ltd share price logo

Biohaven Pharmaceutical Holding Co Ltd Share Price

NYSE: BHVN

Small Cap

$11.00

+0.99

(+9.89%)

as on

Biohaven Pharmaceutical Holding Co Ltd Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $9.95
    $10.58
    downward going graph

    9.55%

    Downside

    -3.82%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $7.48
    $24.06
    downward going graph

    32.00%

    Downside

    118.73%

    Upside

    downward going graph

Biohaven Pharmaceutical Holding Co Ltd share price movements today

Previous Close
$10.01
Open
$10.42
Volume
1.3M
Day's Low - High
$9.95 - $10.58
52 Week Low - High
$7.48 - $24.06

Biohaven Pharmaceutical Holding Co Ltd Historical Returns

1 Month Return
+ 20.79 %
3 Month Return
-16.44 %
1 Year Return
-46.1 %
3 Year Return
-22.13 %
5 Year Return
-85.24 %

Biohaven Pharmaceutical Holding Co Ltd Stock Fundamentals & Key Indicators

Check Biohaven Pharmaceutical Holding Co Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7B

EPS (TTM)

-2.4062

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-698.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-310.75%

Biohaven Pharmaceutical Holding Co Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biohaven Pharmaceutical Holding Co Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.7B-85.24%NA0.00%
BUY$41.3B122.97%133.478.45%
BUY$110.8B101.1%28.4232.94%
NA$37.2BNA131.655.37%
BUY$78.9B49.34%17.9831.41%

Stock Returns calculator for Biohaven Pharmaceutical Holding Co Ltd Stock including INR - Dollar returns

The Biohaven Pharmaceutical Holding Co Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Biohaven Pharmaceutical Holding Co Ltd investment value today

Current value as on today

₹58,689

Returns

-₹41,311

(-41.31%)

Returns from Biohaven Pharmaceutical Holding Co Ltd Stock

-₹45,999 (-46%)

Dollar Impact

₹4,688 (+4.69%)

Analyst Recommendation on Biohaven Pharmaceutical Holding Co Ltd Stock

Based on 17 analysts

BUY

94.12%

Buy

5.88%

Hold

0.00%

Sell

Based on 17 analysts, 94.12% of analysts recommend a 'BUY' rating for Biohaven Pharmaceutical Holding Co Ltd. Average target price of $22.35

Biohaven Pharmaceutical Holding Co Ltd Share Price Target

Get share price movements and forecasts by analysts on Biohaven Pharmaceutical Holding Co Ltd.

What analysts predicted

50.78%UPSIDE

Target Price

$22.35

Current Price

$11

Analyzed by

17 Analysts

Target

$22.35

Biohaven Pharmaceutical Holding Co Ltd target price $22.35, a slight upside of 50.78% compared to current price of $11. According to 17 analysts rating.

Biohaven Pharmaceutical Holding Co Ltd Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
3
-
-
-
-
Gross Profit
0
0
0
0
-1
1
-1
-
-1
0
Operating Income
-110
-153
-183
-333
-178
-189
-221
-211
-169
-142
EBITDA
-109
-151
-181
-331
-176
-187
-219
-209
-172
-142
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
1
1
1
1
1
2
2
1
3
2
Income Before Tax
-105
-145
-178
-319
-160
-186
-221
-197
-173
-145
Income Tax Expense
-3
-1
0
0
0
0
0
0
0
0
Net Income
-102
-144
-179
-319
-160
-186
-221
-198
-173
-145
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-4870.78%
0.00%
0.00%
0.00%
0.00%

Biohaven Pharmaceutical Holding Co Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
462
-
-
-
-
Gross Profit
0
370
-1
-3
-3
-4
Operating Income
-114
-218
-567
-436
-885
-745
EBITDA
-114
-217
-566
-429
-877
-727
Interest Expense
-
41
1
-
-
-
Depreciation
0
1
1
6
7
9
Income Before Tax
-118
-212
-569
-409
-845
-737
Income Tax Expense
0
1
0
-1
0
1
Net Income
-118
-213
-570
-408
-846
-738
Net Profit Margin
0.00%
-46.23%
0.00%
0.00%
0.00%
0.00%

Biohaven Pharmaceutical Holding Co Ltd Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-144
-179
-319
-160
-186
-221
-198
-173
-145
Operating Cash Flow
-114
-102
-167
-141
-170
-165
-167
-145
-130
Investing Cash Flow
-3
34
-97
-93
-87
164
-15
164
-13
Financing Cash Flow
210
3
321
80
272
0
249
0
188
Change in Cash
126
-65
54
-154
14
0
66
19
44

Biohaven Pharmaceutical Holding Co Ltd Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-240
-528
-118
-213
-570
-408
-846
-738
Operating Cash Flow
-197
-377
-75
-145
-297
-331
-582
-609
Investing Cash Flow
-10
-3
-2
0
-304
129
-244
300
Financing Cash Flow
340
434
152
138
767
211
677
439
Change in Cash
132
53
73
-6
165
9
-149
130

Global Institutional Holdings in Biohaven Pharmaceutical Holding Co Ltd

Funds
Holdings
Aberdeen Group PLC
0.46%
Citadel Advisors Llc
1.16%
Holocene Advisors, LP
1.41%
Balyasny Asset Management LLC
1.06%
Brown Advisory Holdings Inc
1.06%

Biohaven Pharmaceutical Holding Co Ltd News & Key Events

  • img

    Today's Timeline - 26 December

    Fri, 05:13 PM

    -

    Biohaven's depression drug failed mid-stage trial, causing shares to slump 13.4%.

Insights on Biohaven Pharmaceutical Holding Co Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, BHVN stock has moved up by 8.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.4% return, outperforming this stock by 47.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 40.2% return, outperforming this stock by 86.3%

About Biohaven Pharmaceutical Holding Co Ltd

Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 2 clinical trial for treating IgA nephropathy; BHV-1600, which is in Phase 1 clinical trial for the treatment of peripartum cardiomyopathy; BHV-8000 that is in Phase 3 clinical trial for treating Parkinson's disease; Opakalim, which is in Phase 3 clinical trial for the treatment of focal epilepsy; BHV-2100 that is in Phase 2 clinical trial for the treatment of pain disorders; and BHV-2000, which is in Phase 2 clinical trial for treating obesity. The company is also developing BHV-1510 that is in Phase 2 clinical trial for the treatment of advanced or metastatic epithelial tumors; and BHV-1530, which is in Phase 2 clinical trial for treating urothelial cancer and other tumors. In addition, its preclinical product pipeline includes BHV-1310 for treating myasthenia gravis; BHV-1320 for treating immune mediated-diseases; BHV-1450 for treating Pemphigus, MuSK MG, and LGI-1 Encephalitis; BHV-1420 for treating membranous nephropathy; BHV-1440 for treating Graves' disease and TED; BHV-6500 for treating type 1 diabetes; BHV-1490 for treating IgM neuropathy and Waldenstrom's; BHV-8100 for treating neurodegenerative diseases; and BHV-1955 for treating tinnitus. The company was formerly known as Biohaven Research Ltd. and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut.
OrganisationBiohaven Pharmaceutical Holding Co Ltd
Headquarters215 Church Street, New Haven, CT, United States, 06510
IndustryBiotechnology
CEODr. Vladimir Coric M.D.
E-voting on sharesClick here to vote

Key Management of Biohaven Pharmaceutical Holding Co Ltd

Name

Title

Mr. Clifford Bechtold M.S.

President & GM of Biohaven Ireland Chief Compliance Officer

Mr. Matthew Buten

Chief Financial Officer

Mr. John McGill

Chief Technology Officer

Mr. Warren Volles J.D.

General Counsel & Chief Legal Officer

Ms. Deb Young

Senior Director of Regulatory Affairs & Operations

Mr. George C. Clark CPA

VP & Chief Accounting Officer

Ms. Jennifer Porcelli

Vice President of Investor Relations

Dr. Vladimir Coric M.D.

Chairman & CEO

Dr. Bruce D. Car DACVP, Ph.D.

Chief Scientific Officer

Ms. Kimberly Gentile

Senior Vice President of Clinical Operations

FAQs

What is Biohaven Pharmaceutical Holding Co Ltd share price today?

Biohaven Pharmaceutical Holding Co Ltd share price today is $11 as on at the close of the market. Biohaven Pharmaceutical Holding Co Ltd share today touched a day high of $10.58 and a low of $9.95.

What is the 52 week high and 52 week low for Biohaven Pharmaceutical Holding Co Ltd share?

Biohaven Pharmaceutical Holding Co Ltd share touched a 52 week high of $24.06 on and a 52 week low of $7.48 on . Biohaven Pharmaceutical Holding Co Ltd stock price today i.e. is closed at $11,which is 54.28% down from its 52 week high and 47.06% up from its 52 week low.

What is Biohaven Pharmaceutical Holding Co Ltd's market capitalisation today?

Biohaven Pharmaceutical Holding Co Ltd market capitalisation is $0.00T as on .

How to invest in Biohaven Pharmaceutical Holding Co Ltd Stock (BHVN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biohaven Pharmaceutical Holding Co Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biohaven Pharmaceutical Holding Co Ltd Shares that will get you 0.1364 shares as per Biohaven Pharmaceutical Holding Co Ltd share price of $11 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Biohaven Pharmaceutical Holding Co Ltd Stock (BHVN) from India?

Indian investors can start investing in Biohaven Pharmaceutical Holding Co Ltd (BHVN) shares with as little as ₹92.575 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹925.75 in Biohaven Pharmaceutical Holding Co Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Biohaven Pharmaceutical Holding Co Ltd share’s latest price of $11 as on April 18, 2026 at 1:29 am IST, you will get 0.9091 shares of Biohaven Pharmaceutical Holding Co Ltd. Learn more about fractional shares .

What are the returns that Biohaven Pharmaceutical Holding Co Ltd has given to Indian investors in the last 5 years?

Biohaven Pharmaceutical Holding Co Ltd stock has given -85.24% share price returns and 24.3% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?